- PMLiVE

mHealth could cut EU’s chronic disease costs

Mobile operators association says compliance and monitoring could be improve through technology

- PMLiVE

Data control: pharma and big data in healthcare

Whether it's big, smart or right, this could be the year pharma and healthcare sees large benefits from data

Lack of social media confidence ‘holding pharma back’

But regulatory restrictions no longer the primary barrier to engagement

- PMLiVE

Roche is drawn to science for YouTube campaign

Therapeutic antibodies, stem cells and Zebrafish tackled in series of fun videos

- PMLiVE

Boehringer/ Lilly launch online diabetes management game

Pharma companies aim to raise awareness of type 2 diabetes complications

Wireless pill bottle wins Boehringer healthcare innovation prize

AdhereTech's winning entry aims to increase patient adherence

- PMLiVE

UK pharmacists get social media guidance

Royal Pharmaceutical Society collects crowd-sourced tools and information on how to use Twitter, Facebook etc

NHS to receive £260m for patient safety technology

Majority of hospital fund will be used for electronic prescribing

UCB and IBM to harness big data for personalised epilepsy care

Joint project could pave the way for therapy area use of IBM's Watson

- PMLiVE

Sanofi partners with PatientsLikeMe to promote its clinical trials

Online patient community will match patients to the pharma company's trials

- PMLiVE

Brazil eHealth pilot improves healthcare access for city poor

Rio de Janeiro project also finds eHealth integration provides major cost savings for health system

- PMLiVE

Europe yet to tap ‘huge potential’ of eHealth

But European Commission working on the challenges that remain, says vice president Neelie Kroes

- PMLiVE

MSD updates Univadis, adds apps

New UK version of its HCP website will allow users to personalise the portal

- PMLiVE

Pfizer launches online home delivery service for Viagra

Partners with CVS/pharmacy on e-commerce initiative

Online Parkinson’s community launched

Britannia Pharmaceuticals' initiative focuses on mid- to late-stages of the disease